Hyundai Bioscience

048410.KQ

7.73 USD

0.42

+5.75%

Overview

Last close

7.73 usd

Market cap

370.97M usd

52 week high

21.12 usd

52 week low

6.67 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

33.7571

Price/Book Value

12.675

Enterprise Value

375.37M usd

EV/Revenue

34.7387

EV/EBITDA

-64.6317

Key financials

Revenue TTM

10.81M usd

Gross Profit TTM

8.47M usd

EBITDA TTM

1.02M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

45.93M usd

Net debt

15.05M usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.